Cytodyn Inc (CYDY)

[SmileyRiley_595]

Well said C-20! I’m confident most (hopefully all) originally invested in CYDY for Leronlimab’s potential! The fundamentals continue to strengthen as the drugs efficacy is proven and CYDY progresses through clinical trials. All investments in biotech are risky and carry a significant amount of volatility. Unfortunately, there are opposing forces that do not want Leronlimab to succeed commercially. There are obvious reasons for that.

We’ve shared our frustrations about the FDA and the manipulation CYDY has gone through. Drug approval is a painstakingly slow process that none seems to have patience to endure. But, I would argue that the FDA will ultimately be the biggest proponent of Leronlimab if/when the drug meets the criteria established by CYDY doctor’s and scientist in clinical trials. The science will not be manipulated like stock symbols.

Remember, CYDY submitted it’s protocol and negotiated with the FDA on what would be considered a successful trial. As investors, we have played our hands and must wait to see what the river card reveals.

Good luck longs!!!